Your session is about to expire
← Back to Search
Computerized Memory Training for Mild Cognitive Impairment (COMET Trial)
COMET Trial Summary
This trial will use a computerized brain training program to see if it can improve memory in people with Mild Cognitive Impairment.
COMET Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.COMET Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your score on the Geriatric Depression Scale is 14 or lower.You have good enough eyesight and hearing to do the tests that measure your brain function.You have had severe depression, bipolar disorder, or other mental health conditions that might make it hard for you to follow the study's instructions.You have been diagnosed with schizophrenia according to the DSM V criteria.You have had a problem with drinking alcohol or using drugs in the past 2 years.You do not have severe memory and thinking problems that would make the doctor think you have Alzheimer's disease.
- Group 1: Neuroplasticity-based Computerized Cognitive Remediation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any openings left in this medical research project?
"Affirmative. According to the clinicaltrials.gov website, this trial is actively recruiting participants with a target enrollment of 20 patients across one location. It was initially posted on August 9th 2022 and last edited on the same day."
Could I potentially qualify for participation in this experiment?
"This experimental study is enrolling 20 candidates aged between 55 and 85 with evidence of cognitive deterioration. To be eligible, patients must demonstrate a reported memory issue, score 0.5 on the Clinical Dementia Rating 16 Global test, have a Mini-Mental State Exam rating from 22 to 30 (inclusive), show no signs of Alzheimer's disease dementia at screening, record less than or equal to 14 for their Geriatric Depression Scale evaluation, possess a regular companion who visits frequently (10 hours per week minimum), showcase general health without any potential interfering ailments or diseases, not currently pregnant nor lactating if female and two years post-men"
Does this research opportunity extend to seniors aged 75 or above?
"This clinical trial has a specified age range of 55 to 85 years, and is currently enrolling patients who meet these conditions."
How many individuals are trialing this medical research?
"Affirmative. As per the clinicaltrials.gov, this research study is now looking for participants to participate in it; the trial was initially publicized on August 9th 2022 and most recently revised on that same day. Approximately 20 individuals have to be enrolled from 1 particular medical site."
Share this study with friends
Copy Link
Messenger